Anny Shai

Also affiliated with Neurological Surgery

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 18 papers. Top paper: “Randomized trial of neoadjuvant vaccination with tumor-cell lysate induces T cell response in low-grade gliomas”.

Randomized trial of neoadjuvant vaccination with tumor-cell lysate induces T cell response in low-grade gliomas

Journal of Clinical Investigation(2021)10.1172/jci151239

N/A

2.0DataRank · unranked

73 citations

Jennie Taylor, Takahide Nejo, David Gibson, Payal B. Watchmaker, Kaori Okada +20 more

Multiplatform molecular analyses refine classification of gliomas arising in patients with neurofibromatosis type 1

Acta Neuropathologica(2022)10.1007/s00401-022-02478-5

N/A

0.598DataRank · unranked

53 citations

Emily A. Sloan, Rohit Gupta, Jasper Wu, Drew Pratt, Harish N. Vasudevan +37 more

Challenges in the discovery of tumor-specific alternative splicing-derived cell-surface antigens in glioma

Scientific Reports(2024)10.1038/s41598-024-56684-0

N/A

0.406DataRank · unranked

14 citations

Lin Wang, Kevin Leung, Albert Wang, Senthilnath Lakshmanachetty, Marco Gallus +19 more

Challenges in the discovery of tumor-specific alternative splicing-derived cell-surface antigens in glioma

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.10.26.564156

N/A

0.269DataRank · unranked

5 citations

Lin Wang, Kevin Leung, Albert Wang, Senthilnath Lakshmanachetty, Marco Gallus +19 more

Temozolomide-induced hypermutation is associated with high-grade transformation, distant recurrence, and reduced survival after transformation in initially low-grade IDH-mutant diffuse gliomas.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.2506

N/A

0.241DataRank · unranked

4 citations

Yu Yao, Javier Villanueva‐Meyer, Matthew Grimmer, Stephanie Hilz, David Solomon +15 more

A combinatory vaccine with IMA950 plus varlilumab promotes effector memory T-cell differentiation in the peripheral blood of patients with low-grade gliomas

Neuro-Oncology(2023)10.1093/neuonc/noad185

N/A

0DataRank · unranked

17 citations

Hirokazu Ogino, Nicholas Butowski, Meghan Tedesco, David R. Gibson, Payal Watchmaker +21 more

Data from CXCL14 Promotes a Robust Brain Tumor-Associated Immune Response in Glioma

(2023)10.1158/1078-0432.c.6531363.v1

N/A

0DataRank · unranked

1 citations

Esraa Mohamed, Schuyler Tong, Katharine Chen, Joydeep Mukherjee, Yunita Lim +12 more

Data from CXCL14 Promotes a Robust Brain Tumor-Associated Immune Response in Glioma

(2023)10.1158/1078-0432.c.6531363

N/A

0DataRank · unranked

0 citations

Esraa Mohamed, Schuyler Tong, Katharine Chen, Joydeep Mukherjee, Yunita Lim +12 more

Glioblastoma evolution and heterogeneity from a 3D whole-tumor perspective

Cell(2024)10.1016/j.cell.2023.12.013

N/A

0DataRank · unranked

207 citations

Qixuan Wang, Patrick G. Schupp, Ana Nikolić, Stephanie Hilz, Chibo Hong +25 more

Longitudinal multimodal profiling of IDH-wildtype glioblastoma reveals the molecular evolution and cellular phenotypes underlying prognostically different treatment responses

Neuro-Oncology(2024)10.1093/neuonc/noae214

N/A

0DataRank · unranked

25 citations

Nadeem Al-Adli, Jacob S. Young, Rohit Gupta, Ramin A. Morshed, Jasper Wu +24 more

Quantitative Assessment of Preanalytic Variables on Clinical Evaluation of PI3/AKT/mTOR Signaling Activity in Diffuse Glioma

Modern Pathology(2024)10.1016/j.modpat.2024.100488

N/A

0DataRank · unranked

3 citations

Esraa Mohamed, Viva Voong, Stephanie Hilz, Marisa Lafontaine, Anny Shai +11 more

Longitudinal tumor-wide sampling of glioblastoma reveals diverse genomic drivers of the earliest clonal expansion at diagnosis and recurrence.

Journal of Clinical Oncology(2024)10.1200/jco.2024.42.16_suppl.2009

N/A

0DataRank · unranked

1 citations

Chibo Hong, Lee Chen, Ivan Smirnov, Joanna J. Phillips, Anny Shai +3 more

Recurrent tumor and treatment-induced effects have different MR signatures in contrast enhancing and non-enhancing lesions of high-grade gliomas

Neuro-Oncology(2020)10.1093/neuonc/noaa094

N/A

0DataRank · unranked

8 citations

Sarah J. Nelson, Qiuting Wen, Joanna J. Phillips, Anny Shai, Annette M. Molinaro +11 more

3D spatial sampling to quantify morphologic heterogeneity in isocitrate dehydrogenase-wildtype glioblastoma

Journal of Neuropathology & Experimental Neurology(2025)10.1093/jnen/nlaf101

N/A

0DataRank · unranked

1 citations

Sol Beccari, Elaheh Hashemi, Birgit Kriener, Radhika Mathur, Marisa Lafontaine +9 more

Temozolomide-induced hypermutation is associated with distant recurrence and reduced survival after high-grade transformation of low-grade IDH-mutant gliomas

Neuro-Oncology(2021)10.1093/neuonc/noab081

N/A

0DataRank · unranked

122 citations

Javier Villanueva‐Meyer, Matthew Grimmer, Stephanie Hilz, David A. Solomon, Serah Choi +17 more

PI3K/AKT/mTOR signaling pathway activity in IDH-mutant diffuse glioma and clinical implications

Neuro-Oncology(2022)10.1093/neuonc/noac064

N/A

0DataRank · unranked

80 citations

Anupam Kumar, Yalan Zhang, Albert S Wang, Katharine Chen, Yunita Lim +10 more

CXCL14 Promotes a Robust Brain Tumor-Associated Immune Response in Glioma

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-21-2830

N/A

0DataRank · unranked

66 citations

Esraa Mohamed, Schuyler Tong, Katharine Chen, Joydeep Mukherjee, Yunita Lim +12 more

Whole tumor analysis reveals early origin of the TERT promoter mutation and intercellular heterogeneity in TERT expression

Neuro-Oncology(2023)10.1093/neuonc/noad231

N/A

0DataRank · unranked

18 citations

Chibo Hong, Abigail K. Suwala, Stephanie Hilz, Radhika Mathur, David A. Solomon +9 more